The Dutch aesthetic devices market is anticipated to grow at a CAGR of 12.1% during the forecast period.
The COVID-19 pandemic impacted Dutch healthcare during the pandemic. The cosmetic and aesthetic device manufacturers had to shut down their production and supply units due to the lockdown that was imposed at the beginning of the COVID-19 outbreak. However, with resumed cosmetic clinics and plastic surgery clinics, the market studied is expected to regain its full potential in the next three to four years.
Certain factors propelling the market growth are the increasing number of cosmetic surgeries and the rising adoption of minimally invasive devices. For instance, according to the DBIR 2020 Annual Report, 3,990 breast reconstructive procedures were reported in 2020 in the Netherlands. In addition, of these reconstructive surgeries, 1,760 (44%) were insertion-only procedures, 1,710 (43%) were replacement surgeries, and 520 (13%) were explantation-only procedures. Thus, the high number of aesthetic and cosmetic procedures performed in the country is expected to increase the demand for advanced aesthetic devices, propelling the market growth.
The concern of people about their appearance is gradually rising in the country. Thus, there is an increase in the number of cosmetic surgeries performed annually. Although the rate of increase is low, the fact remains that people are getting more concerned about their appearance, especially with the increasing standard of living.
In addition, the rising population and obese population, coupled with rising awareness about aesthetic procedures among the population, is also contributing to the market growth. For instance, according to the 2022 statistics published by the UNPF, about 64% of the people living in the Netherlands were aged between 15-64 years. In addition, as per the same source, 21% of the population was aged 65 years and above in 2022. Additionally, as per the 2022 statistics published by World Obesity, 14.7% of men and 15.7% of women were obese in the Netherlands in 2020. Thus, population growth and obesity are expected to increase the demand for aesthetic procedures such as facelifting, anti-aging procedures, liposuction, and reconstruction procedures, which is further expected to boost the demand for aesthetic devices in the country, propelling the market growth.
Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period. However, the poor reimbursement scenario is likely to impede market growth over the forecast period.
The rising burden of breast cancer in the country is the key factor driving the segment’s growth. For instance, as per GLOBOCAN 2020 fact sheet, about 60,080 new breast cancer cases were reported in the country in 2020. Additionally, according to the DBIR Annual Report, about 47% of postoperative systemic antibiotics were administered more frequently for reconstructive procedures in the country in 2020. In addition, as per the same source, 66% of nipple guards were used for aesthetic procedures in 2020. Furthermore, 12,451 breast implant surgeries were conducted in the Netherlands in 2020, including 2,721 reconstructive surgeries after mastectomy for cancer, 535 reconstructive surgeries after prophylactic mastectomy, and 9,024 cosmetic augmentation procedures.
Furthermore, from the same source, 3,990 reconstructive procedures were reported in 2020 in the Netherlands. In addition, of these reconstructive surgeries, 1,760 (44%) were insertion-only procedures, 1,710 (43%) were replacement surgeries, and 520 (13%) were explantation-only procedures. Thus, the high number of aesthetic and cosmetic procedures performed in the country is expected to increase the demand for advanced aesthetic devices, propelling segment growth.
Therefore, owing to the factors such as the high burden of breast cancer and increasing breast implant surgeries, the segment studied is expected to grow over the forecast period.
Botulinum toxin is a neurotoxic protein produced by the bacterium Clostridium botulinum. The injections of botulinum toxin tend to block the nerve signals to the muscle in which it is injected. When the muscle is not able to contract without a signal, it results in diminishing or decreasing unwanted facial wrinkles or appearance. As a result, highly diluted concentrations of botulinum toxin are used for cosmetic and non-cosmetic purposes, such as for the treatment of frown lines between the eyebrows, dystonia, chronic migraine, and other purposes. Some of the brands used in the Netherlands include Azzalure, Dysport, and Botox.
Additionally, the rising company activities in developing products, conducting clinical trials, and increasing product launches contribute to market growth. For instance, in April 2022, AbbVie conducted a Phase II clinical study to evaluate the efficacy and safety of botulinum toxin type A (AGN-151607) injections into the epicardial fat pads, foci of ganglionic plexi in patients.
Therefore, owing to the factors such as the rising demand and awareness for cosmetic procedures, the segment studied is expected to grow during the forecast period.
This product will be delivered within 2 business days.
The COVID-19 pandemic impacted Dutch healthcare during the pandemic. The cosmetic and aesthetic device manufacturers had to shut down their production and supply units due to the lockdown that was imposed at the beginning of the COVID-19 outbreak. However, with resumed cosmetic clinics and plastic surgery clinics, the market studied is expected to regain its full potential in the next three to four years.
Certain factors propelling the market growth are the increasing number of cosmetic surgeries and the rising adoption of minimally invasive devices. For instance, according to the DBIR 2020 Annual Report, 3,990 breast reconstructive procedures were reported in 2020 in the Netherlands. In addition, of these reconstructive surgeries, 1,760 (44%) were insertion-only procedures, 1,710 (43%) were replacement surgeries, and 520 (13%) were explantation-only procedures. Thus, the high number of aesthetic and cosmetic procedures performed in the country is expected to increase the demand for advanced aesthetic devices, propelling the market growth.
The concern of people about their appearance is gradually rising in the country. Thus, there is an increase in the number of cosmetic surgeries performed annually. Although the rate of increase is low, the fact remains that people are getting more concerned about their appearance, especially with the increasing standard of living.
In addition, the rising population and obese population, coupled with rising awareness about aesthetic procedures among the population, is also contributing to the market growth. For instance, according to the 2022 statistics published by the UNPF, about 64% of the people living in the Netherlands were aged between 15-64 years. In addition, as per the same source, 21% of the population was aged 65 years and above in 2022. Additionally, as per the 2022 statistics published by World Obesity, 14.7% of men and 15.7% of women were obese in the Netherlands in 2020. Thus, population growth and obesity are expected to increase the demand for aesthetic procedures such as facelifting, anti-aging procedures, liposuction, and reconstruction procedures, which is further expected to boost the demand for aesthetic devices in the country, propelling the market growth.
Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period. However, the poor reimbursement scenario is likely to impede market growth over the forecast period.
Netherlands Aesthetic Devices Market Trends
Breast Implants Segment Expects to Register a Significant Growth Over the Forecast Period
The breast implant segment is expected to witness significant growth in the aesthetics devices market during the forecast period owing to the factors such as the rising prevalence of breast cancer among the population, increasing awareness about the beauty and physical appearance, and the availability of a variety of breast implants.The rising burden of breast cancer in the country is the key factor driving the segment’s growth. For instance, as per GLOBOCAN 2020 fact sheet, about 60,080 new breast cancer cases were reported in the country in 2020. Additionally, according to the DBIR Annual Report, about 47% of postoperative systemic antibiotics were administered more frequently for reconstructive procedures in the country in 2020. In addition, as per the same source, 66% of nipple guards were used for aesthetic procedures in 2020. Furthermore, 12,451 breast implant surgeries were conducted in the Netherlands in 2020, including 2,721 reconstructive surgeries after mastectomy for cancer, 535 reconstructive surgeries after prophylactic mastectomy, and 9,024 cosmetic augmentation procedures.
Furthermore, from the same source, 3,990 reconstructive procedures were reported in 2020 in the Netherlands. In addition, of these reconstructive surgeries, 1,760 (44%) were insertion-only procedures, 1,710 (43%) were replacement surgeries, and 520 (13%) were explantation-only procedures. Thus, the high number of aesthetic and cosmetic procedures performed in the country is expected to increase the demand for advanced aesthetic devices, propelling segment growth.
Therefore, owing to the factors such as the high burden of breast cancer and increasing breast implant surgeries, the segment studied is expected to grow over the forecast period.
Botulinum Toxin Segment is Expected to Have Significant Market Share Over the Forecast Period
The botulinum toxin segment is expected to witness significant growth in the aesthetics market in the Netherlands during the forecast period owing to factors such as the rise in demand for minimally invasive cosmetic methods and a higher number of beauty-conscious populations.Botulinum toxin is a neurotoxic protein produced by the bacterium Clostridium botulinum. The injections of botulinum toxin tend to block the nerve signals to the muscle in which it is injected. When the muscle is not able to contract without a signal, it results in diminishing or decreasing unwanted facial wrinkles or appearance. As a result, highly diluted concentrations of botulinum toxin are used for cosmetic and non-cosmetic purposes, such as for the treatment of frown lines between the eyebrows, dystonia, chronic migraine, and other purposes. Some of the brands used in the Netherlands include Azzalure, Dysport, and Botox.
Additionally, the rising company activities in developing products, conducting clinical trials, and increasing product launches contribute to market growth. For instance, in April 2022, AbbVie conducted a Phase II clinical study to evaluate the efficacy and safety of botulinum toxin type A (AGN-151607) injections into the epicardial fat pads, foci of ganglionic plexi in patients.
Therefore, owing to the factors such as the rising demand and awareness for cosmetic procedures, the segment studied is expected to grow during the forecast period.
Netherlands Aesthetic Devices Market Competitor Analysis
The Netherlands aesthetic devices market is moderately competitive. The companies dealing in the aesthetics market have been leveraging mergers and acquisitions, internal research and development, and new partnerships to expand their businesses in other regions, especially in promising emerging markets. Some of the companies currently dominating the market are AbbVie (Allergan Inc.), Alma Lasers, Entercare, Johnson and Johnson, Lumenis Inc., Galderma SA (Nestle), and Sciton Inc, among others.Additional benefits of purchasing the report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION (Market Size by Value - USD million)
6 COMPETITIVE LANDSCAPE
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Allergan Inc.
- Alma Lasers
- Entercare
- Johnson & Johnson
- Lumenis Inc.
- Galderma SA (Nestle)
- Sciton Inc.
Methodology
LOADING...
